InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025
NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical trial (NCT06166836; NCT05379946)...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma
SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
May 19: World Inflammatory Bowel Disease Day | Healthy Gut, Happy Life
SHENZHEN, China, May 26, 2025 /PRNewswire/ -- May 19 is designated as World Inflammatory Bowel Disease (IBD) Day, aimed at raising public awareness of IBD patients and improving their quality of life and medical care. The European Federation of...
New leadership, bold vision: Rakshit Choudhary appointed CEO of Deriv
Founder Jean-Yves Sireau transitions to Founder role after 25 years of leadership. CYBERJAYA, Malaysia, May 21, 2025 /PRNewswire/ -- Deriv, a global leader in online trading, has announced a major leadership transition as Rakshit Choudhary assumes...
CLEAR's Patented Breakthrough: 3 Global Patents & 200 Dermatologists Validate Next-Gen Dandruff Solutions
SHANGHAI, April 30, 2025 /PRNewswire/ -- Recently, CLEAR, Unilever's premium professional anti-dandruff brand, held a grand launch event at TANK Shanghai, debuting its first-ever SCALPCEUTICALS PRO RANGE—a groundbreaking series born from over a...
SunCar Technology Reports 2024 Annual Results
NEW YORK, April 29, 2025 /PRNewswire/ -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), an innovative leader in cloud-based, software-focused B2B auto eInsurance and auto services in China, today reported annual financial...
2 Billion USD Polypropylene (PP) Production Plant and Terminal Investment to Contribute $300 Million Annually to Türkiye's Trade Balance
ISTANBUL, April 25, 2025 /PRNewswire/ -- Rönesans Holding, one of Europe's leading contracting and investment groups, has initiated one of the largest private sector investments in Türkiye to date: the construction of a new Polypropylene (PP)...
Kelun-Biotech's novel ADC drug SKB518 has been granted the clearance of IND from the United States Food and Drug Administration (FDA)
CHENGDU, China, April 21, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has been granted the clearance of investigational new drug (IND) application to initiated the clinical study...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
SAN FRANCISCO and SUZHOU, China, March 31, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Progress has been achieved in the pilot construction of the micro-application cluster for the State Grid power distribution network in Xinjiang
URUMQI, China, March 27, 2025 /PRNewswire/ -- On March 25, State Grid Xinjiang Electric Power Co., Ltd. successfully completed the deployment and testing of the distribution network micro-application cluster, marking a phased advancement in the...